Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
International Journal of Clinical Practice|May 23, 2013
Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studiesV W Nitti, V Khullar, P van Kerrebroeck, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 29, 2012
Neoadjuvant chemoradiotherapy and multivisceral resection for primary locally advanced adherent colon cancer: a single institution experienceM Cukier, A J Smith, L Milot, et al.
British Journal of Cancer|February 18, 2015
Complications following surgery with or without radiotherapy or radiotherapy alone for prostate cancerC J D Wallis, P Cheung, S Herschorn, et al.
The Journal of Urology|September 1, 1996
Randomized, prospective, controlled study comparing radical prostatectomy alone and neoadjuvant androgen withdrawal in the treatment of localized prostate cancer. Canadian Urologic Oncology GroupS L Goldenberg, L H Klotz, J Srigley, et al.
Urology|March 1, 1996
A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasiaM M Elhilali, E W Ramsey, J Barkin, et al.
Cancer|October 15, 1981
Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study GroupC G Moertel, S Frytak, R G Hahn, et al.
Cancer|July 1, 1978
Randomized phase II clinical trial of adriamycin, methotrexate, and actinomycin-D in advanced measurable pancreatic carcinoma: a Gastrointestinal Tumor Study Group ReportP S Schein, P T Lavin, C G Moertel, et al.
Pageof 10